Breakthrough made in herpes antiviral molecule development
Researchers have created a new method of potentially treating herpes virus, by targeting the physical properties of the viral genome.
List view / Grid view
Researchers have created a new method of potentially treating herpes virus, by targeting the physical properties of the viral genome.
Researchers have modified the COVID-19 Spike protein for use in vaccines, which produces up to 10 times more protein than that of an earlier synthetic versions.
A new study has shown that while chloroquine protects African green monkey kidney cells from SARS-CoV-2 infection, it does not protect human lung cells.
A novel drug has been created which prevented the blood clotting associated with heart attacks and strokes in pre-clinical studies.
Drug Target Review highlights five of the latest imaging advancements in the field of microscopy.
The vaccine candidate repRNA-CoV2S elicited both antibody and T cell responses after just two injections in mice and macaques.
Researchers reveal IgHV3-53 is the most common immunoglobulin mutation used to target the receptor binding domain on the SARS-CoV-2 spike protein.
Researchers who developed a machine learning algorithm to predict the adverse effects of new drug compounds have released it as an open source tool.
The bioreactor-based system incorporates liver cells to perform the detoxifying functions of the liver and was tested on pigs with acute liver failure.
This article outlines the ideal scientific research that should be conducted to design a prophylactic to combat COVID-19.
Ophthalmology and engineering combine in a novel nanoparticle-delivered gene therapy approach to treating wet age-related macular degeneration.
Researchers have found that a plasma exchange process can act as a molecular reset button for old blood, improving the health of ageing mice.
The genomic research platform will initially be used to help fast-track COVID-19 drug research and development, before being leveraged against other diseases, such as cancer.
The vitamin K-based drug has a unique structure which researchers believe makes it effective in controlling even medication-resistant seizures.
To overcome the issues of current analgesics, researchers reveal a new class of non-narcotic pipeline drugs based on acetaminophen.